Breaking News Instant updates and real-time market news.

GE

General Electric

$9.16

-0.34 (-3.58%)

06:52
08/12/19
08/12
06:52
08/12/19
06:52

General Electric fundamentals 'continue to look negative,' says JPMorgan's Tusa

JPMorgan analyst Stephen Tusa came away from General Electric's Q2 results with no change to his "well below consensus view." GE Power needs a positive core profit contribution on $1B in negative mix revenue headwind "to just get back to breakeven," Tusa tells investors in a research note. Further, Aviation needs 35% growth in its Military business to hit guidance, adds the analyst. Despite the Street's enthusiasm around a beat to low guidance, GE's fundamentals "continue to look negative," argues Tusa. He keeps an Underweight rating on shares of General Electric with a $5 price target. The stock closed Friday down 34c to $9.15.

  • 09

    Sep

  • 30

    Oct

GE General Electric
$9.16

-0.34 (-3.58%)

07/18/19
07/18/19
DOWNGRADE

Neutral
Allegheny Technologies cut to Neutral at Longbow on reduced aerospace visibility
As previously reported, Longbow analyst Christopher Olin downgraded Allegheny Technologies (ATI) to Neutral from Buy, citing "too many negative survey points" to remain positive on the visibility for the company commercial aerospace demand. The analyst warns that a potential rate cut assessment that may be issued by Boeing (BA) or General Electric (GE) when they announce results could weigh on investor sentiment for Allegheny Technologies in the second half of 2019 and believes that the FY20 earnings guidance for the entire specialty materials group could come under pressure.
07/23/19
GDHS
07/23/19
NO CHANGE
Target $7
GDHS
Underperform
GE set Q2 cash guidance bar 'excessively' low, says Gordon Haskett
Gordon Haskett analyst John Inch said he expects General Electric to significantly beat its Industrial free cash flow guidance of ($1B-$2B) when the company reports second quarter results next week, but that reflects the degree to which GE "set the cash expectations bar at an (excessively) low level," according to Inch. Looking ahead, tougher comparisons and a waning global economic outlook could make for a tougher road in terms of cash flow, said Inch, who keeps an Underperform rating and $7 price target on GE shares.
07/31/19
JPMS
07/31/19
NO CHANGE
JPMS
Underweight
JPMorgan's Tusa says GE guidance drivers 'low quality,' would sell into strength
JPMorgan analyst Stephen Tusa says General Electric reported an operation miss in Q2 driven by a material miss at its Aviation unit and it also reported free cash flow that missed his estimate. While the company raised its headline guidance, the drivers of the raise "seem low quality" as the company's segments "are trending at best in line," Tusa tells investors. He would sell any strength today in the shares following the report and keeps an Underweight rating on shares of General Electric. The stock is up about 4% in pre-market trading, but Tusa contends that "like in the past, the underlying core fundamentals are actually a bit worse."
08/01/19
WBLR
08/01/19
NO CHANGE
WBLR
Outperform
GE operational and financial turnaround building momentum, says William Blair
General Electric's Q2 report yesterday "included further tangible evidence" that its operational and financial turnaround is beginning to build momentum, William Blair analyst Nicholas Heymann tells investors in a research note. GE's year-to-date free cash flow use was $2.2B, down $0.8B from the first half of 2018, while its Industrial organic sales grew sequentially to 7% from 5%, Heymann points out. The analyst reaffirms an Outperform rating on the shares. GE's fundamental prospects and underlying value "continue to remain extremely divergent within the investment community," says Heymann. However, he sees "growing irrefutable evidence that the worst is not only past but also that GE's fundamental forward visibility is gradually beginning to improve as its financial stability returns." The analyst pegs GE's underlying intrinsic value, with no value assigned to Power, between $14 and $16 per share. This range now seems to be a "highly feasible base-case valuation" for the stock over the next 6-12 months, according to Heymann. Shares of General Electric closed yesterday up 2c to $10.45.

TODAY'S FREE FLY STORIES

08:29
08/20/19
08/20
08:29
08/20/19
08:29
Conference/Events
Seaport Global to hold a conference »

St. Louis Coal Conference…

RNET

RigNet

$7.58

0.22 (2.99%)

08:27
08/20/19
08/20
08:27
08/20/19
08:27
Hot Stocks
Ocyan signs multi-year agreement with RigNet for Intelie Live »

RigNet announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 06

    Sep

SRPT

Sarepta

$120.16

-4.81 (-3.85%)

08:26
08/20/19
08/20
08:26
08/20/19
08:26
Recommendations
Sarepta analyst commentary  »

FDA's CRL on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JMIA

Jumia Technologies

$15.45

2.31 (17.58%)

08:25
08/20/19
08/20
08:25
08/20/19
08:25
Upgrade
Jumia Technologies rating change  »

Morgan Stanley upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

CGIX

Cancer Genetics

$0.12

0.006 (5.26%)

08:25
08/20/19
08/20
08:25
08/20/19
08:25
Hot Stocks
Breaking Hot Stocks news story on Cancer Genetics »

Cancer Genetics says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:24
08/20/19
08/20
08:24
08/20/19
08:24
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGIX

Cancer Genetics

$0.12

0.006 (5.26%)

08:24
08/20/19
08/20
08:24
08/20/19
08:24
Earnings
Cancer Genetics reports Q2 cont. ops. EPS (1c) vs. (3c) last year »

Reports Q2 revenue $1.5M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

$0.00

(0.00%)

08:24
08/20/19
08/20
08:24
08/20/19
08:24
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$104.15

1.42 (1.38%)

08:24
08/20/19
08/20
08:24
08/20/19
08:24
Earnings
Medtronic sees Q2 EPS $1.27-$1.29, consensus $1.28 »

Sees Q2 revenue similar…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 04

    Sep

  • 09

    Sep

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:24
08/20/19
08/20
08:24
08/20/19
08:24
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$6.70

0.29 (4.52%)

, ATRS

Antares Pharma

$3.12

-0.015 (-0.48%)

08:24
08/20/19
08/20
08:24
08/20/19
08:24
Hot Stocks
Teva announces availability of EpiPen Jr generic equivalent »

Teva (TEVA) announced…

TEVA

Teva

$6.70

0.29 (4.52%)

ATRS

Antares Pharma

$3.12

-0.015 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

IYT

iShares Transportation Average

$181.54

1.76 (0.98%)

08:24
08/20/19
08/20
08:24
08/20/19
08:24
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:24
08/20/19
08/20
08:24
08/20/19
08:24
Conference/Events
Federal Reserve Board Vice Chairman participates in a panel discussion »

Federal Reserve Board of…

XLK

Technology Select Sector SPDR

$79.48

1.21 (1.55%)

08:23
08/20/19
08/20
08:23
08/20/19
08:23
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$58.30

1.25 (2.19%)

08:23
08/20/19
08/20
08:23
08/20/19
08:23
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$117.31

1.44 (1.24%)

08:23
08/20/19
08/20
08:23
08/20/19
08:23
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ODP

Office Depot

$1.51

0.07 (4.86%)

08:23
08/20/19
08/20
08:23
08/20/19
08:23
Recommendations
Office Depot analyst commentary  »

Office Depot price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$57.05

0.42 (0.74%)

08:23
08/20/19
08/20
08:23
08/20/19
08:23
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$61.74

0.39 (0.64%)

08:22
08/20/19
08/20
08:22
08/20/19
08:22
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$60.82

0.61 (1.01%)

08:22
08/20/19
08/20
08:22
08/20/19
08:22
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$91.41

0.88 (0.97%)

08:22
08/20/19
08/20
08:22
08/20/19
08:22
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$150.13

1.59 (1.07%)

08:22
08/20/19
08/20
08:22
08/20/19
08:22
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$261.32

2.51 (0.97%)

08:21
08/20/19
08/20
08:21
08/20/19
08:21
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PUFXF

Agraflora Organics

$0.00

(0.00%)

08:21
08/20/19
08/20
08:21
08/20/19
08:21
Hot Stocks
Agraflora Organics to acquire 50% of Eurasia Infused Cosmetics »

AgraFlora Organics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIK

Michaels

$5.42

0.235 (4.54%)

08:21
08/20/19
08/20
08:21
08/20/19
08:21
Recommendations
Michaels analyst commentary  »

Michaels price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.